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Type I IFNs, such as interferon alpha and interferon beta, are key regulators of the adaptive
immune response during infectious diseases. Type I IFNs are induced upon infection, bind
interferon a/b receptors on T-cells and activate intracellular pathways. The activating and
inhibitory consequences of type I IFN-signaling are determined by cell type and cellular
environment. The neonatal immune system is associated with increased vulnerability to
infectious diseases which could partly be explained by an immature CD4+ T-cell
compartment. Here, we show low IFN-b-mediated inhibition of CD4+ T-cell proliferation,
phosphorylation of retinoblastoma protein and cytokine production in human newborns
compared to adults. In addition, both naïve and total newborn CD4+ T-cells are unable to
induce the cell-cycle inhibitor p21 upon exposure to IFN-b in contrast to adults. The
distinct IFN-b-signaling in newborns provides novel insights into T cell functionality and
regulation of T cell-dependent inflammation during early life immune responses.
Keywords: interferon beta, respiratory syncytial virus, newborns, immunity, CD4 T cells, proliferation, cell cycle,
cyclic-dependent kinase inhibitor/p21
INTRODUCTION
Newborns encounter a large variety of infectious microorganisms during the first months of life.
Whereas antibodies are transferred from the mother leading to passive protection, T cell-mediated
immunity has to be developed by the newborn itself. A delicate balance between accurate T cell
activation and prevention of T cell-mediated immunopathology is essential to mount a protective
immune response. Clinical presentation and disease progression of many infectious diseases are
different in newborns compared to adults, which raises the question which regulatory mechanisms
of T-cell-mediated inflammation are present in newborns. The low production of cytokines such as
interferon gamma (IFN-g) in newborns indicates a reduced activation of CD4+ T cells (1). On the
other hand, activated CD4+ T cells and T cell-mediated immunopathology has been observed
during neonatal sepsis (2) and severe viral infections, including neonatal RSV infections (3). Type I
IFNs, such as interferon alpha (IFN-a) and interferon beta (IFN-b), are key regulators of the
adaptive immune response, including CD4+ T cells (4). Type I IFNs bind the interferon a/b receptor
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(IFNAR1/2) and induce a variety of intracellular signals. Type I
IFNs can directly inhibit or activate CD4+ T cells and thereby
affect the proliferation and cytokine production by CD4+ T cells
(4). For instance, type I IFNs inhibit proliferation of T cells
during viral infections in mice (5). In addition, IFN-b inhibits the
proliferation of adult T cells in vitro (6) and treatment of adults
with multiple sclerosis with IFN-b inhibits the ex vivo
proliferation of CD4+ T cells (7). However, no study so far
compared the effects of IFN-b on newborns with adults. We
hypothesize that the regulation of CD4+ T cells by type I IFNs is
different in newborns compared to adults. The goal of this study
was to determine the differential effects of IFN-b on newborn
CD4+ T cell functionality compared to adults. Newborn and
adult mononuclear cells (MCs) were used to characterize IFN-b-
dependent and RSV-induced regulation of T cells. Isolated CD4+
T cells, including naïve CD4+ T cells, were collected to gain
insights into T cell-intrinsic mechanisms in newborns and adults
that depend on type I IFNs. Dissecting the effects of type I IFNs
and IFNAR signaling in newborn and adult CD4+ T cells will
provide novel insights into the ontogeny of T cell functionality




Green fluorescent protein (GFP)-labeled RSV A2 (rgRSV30),
kindly proved by Dr. M.E. Peeples, was cultured on HeLa cells
(ATCC, CCL-2) as previously described (8). The virus stock was
snap-frozen and stored at -80°C.
Cell Isolation
After cesarean section delivery of the placenta, human newborn
cord blood was collected from the umbilical cord. Premature
births and birth to HIV-positive mothers were excluded.
Peripheral blood was collected form healthy adult volunteers.
Human experimental guidelines of the Regional Committee on
Research involving Human Subjects Arnhem-Nijmegen, were
observed, following protocols approved by the local institutional
review boards. Newborn or adult blood was layered onto
Lymphoprep (Stemcell Technologies) to collect CBMCs and
PBMCs, respectively. CD4+ and CD8+ T cells were isolated
from MC fractions by positive selection with magnetic CD4
and CD8 microbeads, respectively, according to the
manufacturer’s instructions (Miltenyi Biotec, Auburn, CA).
Purity of CD4+ or CD8+ T cell preparations was consistently >
93%. When indicated, CD25+ cells were depleted from isolated T
cells. For this, untouched CD4+ T cells were isolated from whole
blood (RosetteSep CD4 Enrichment Kit; Stemcell Technologies)
and subsequently CD25high T cells were depleted using magnetic
CD25 microbeads (Miltenyi Biotec, Auburn, CA). More than
80% of CD25+ T cells were depleted as confirmed by flow
cytometry (Supplementary Figure 2C). Naïve CD4+ T cells
were isolated from MC fraction by negative selection (Naïve
CD4+ T cell isolation kit II, human; Miltenyi Biotec, Auburn,
CA) followed by a positive selection with magnetic CD27+
microbeads to remove terminally differentiated CD4+ T cells
(9). RPMI 1640 medium (Invitrogen) + 10% fetal calf serum
(FCS) + 2 mM L-Glutamine was used as culture medium.
Cell Stimulation
Each 96-well plate was filled with 5 x 105 CMBCs or PBMCs per
well or with 1 x 105 isolated newborn or adult T cells per well. In
separate experiments, the supernatants from RSV-stimulated
MCs (sup RSV-MC) were harvested, centrifuged and used for
subsequent stimulation of cells from different donors. No viral
particles, determined by fluorescent staining of RSV fusion
protein, were detected after exposure of HeLa cells to
supernatant from RSV-stimulated cells (data not shown). For
the proliferation assay, MCs or isolated T cells were labeled with
CFSE, respectively 5 µg/ml or 1 µg/ml. Cells were exposed to RSV
(MOI 0.04, 0.2 or 1), recombinant human IFN-a (PBL
Interferon Source, NJ) or recombinant human IFN-b (PBL
Interferon Source, NJ) for 24h. Subsequently, MCs or isolated
T cells were activated with respectively PHA (1 µg/ml; Sigma) or
CD3/CD28 beads (Dynabeads ThermoFisher Scientific) for 72h.
When indicated, the human interferon alpha/beta receptor
(IFNAR2) was blocked with monoclonal antibodies against
IFNAR2 (5 µg/ml, IgG2a, clone MMHAR-2, PBL Interferon
Source, NJ) or isotype controls for 1h before stimulation. All
conditions were performed in duplicate.
Flow Cytometry
Proliferation was determined by CFSE fluorescence (Figure 1A).
The following fluorochrome-labeled monoclonal antibodies were
used for immunophenotyping: CD3 Alexa Fluor 647, CD4
PerCp-Cy5.5, CD8 APC-H7, CD45RA Pe-Cy7, CD27 V500,
CD25 Alexa Fluor 700, CD127 V450 (BD Biosciences). Mean
fluorescence intensity of IFNAR1 PE and IFNAR2 PE (PBL
Interferon Source, NJ) were determined for the expression of
IFNAR1 and IFNAR2. 7-Aminoactinomycin D (7-AAD) was
used to measure cell death. Cells were analyzed with LSR II
flow cytometer.
Phosflow
Isolated CD4+ T cells were incubated with medium for 2h at 37°
C to reduce background phosphorylation after which IFN-b was
added. CytoFix (BD Biosciences) was added to the cells for
10 min at 37°C. Cells were washed with PBS/1%BSA and
permeabilized with Perm Buffer III (BD Biosciences) for
30 min on ice. Cells were washed and labeled with the
following monoclonal antibodies: STAT1(pY701)-PE and Rb
(pS780)-Alexa Fluor 647; BD Biosciences) for 30 min at RT.
Cells were analyzed with LSR II flow cytometer.
Quantitative Real-Time Polymerase
Chain Reaction (qRT-PCR)
After stimulation, cells were stored in lysis buffer containing 1% b-
mercaptoethanol at -80 °C. RNA was extracted according to the
manufacturer’s protocol (Macherey-Nagel). cDNA was synthesized
by iScript (BioRad) and stored at -20°C. qRT-PCRwas conducted on
a CFX96 (BioRad) using Taqman gene expression assays
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(GAPDH:Hs02758991_g1, CDKN1A/p21: Hs00355782_m1,
CDKN1B/p27: Hs01597599_m1, p53: Hs01034249_m1, IRF9
(Hs00196051_m1), STAT1: Hs01013996_m1, STAT2:
Hs01013123_m1). The PCR program consisted of 5 min at 96°C,
followed by 50 cycles of 15 s at 96°C and 45 s at 60°C. CFXManager
3.0 (BioRad) was used for analysis. Data were normalized and DCt
was calculated by subtracting the Ct value of the housekeeping gene
GAPDH from the Ct value of the target gene. Relative expression




Tumor necrosis factor (TNF; R&D Systems) and interleuking 10
(IL-10; Sanquin PeliKine) concentrations were measured in the
cell supernatants by ELISA according to the manufacturer’s
instructions with a lower limit of detection of 39 pg/ml. All
conditions were measured in duplicate.
Statistical Analysis
Statistical analyses employed the Wilcoxon matched-pairs signed
rank test for paired analysis between two conditions and repeated
measures ANOVA with Bonferroni’s Multiple Comparison Test for
paired analysis between more than two conditions. Comparison
between newborns and adults employed Mann–Whitney U test.
Comparison betweenmore than two groups employed the Kruskal–
Wallis test followed by Dunn’s Multiple Comparison Test. Tests
were considered significant if P<0.05. All statistical analyses were
done with GraphPad Prism.
RESULTS
Low IFN-b-Mediated Inhibition of T Cell
Proliferation in Newborns
Cord blood mononuclear cells (CBMCs) and adult peripheral
blood mononuclear cells (PBMCs) were used to assess whether
human newborn T cells are differently modulated by type I IFNs
compared to adults. The effect of type I IFNs on T cell
proliferation was determined by exposing newborn and adult
MCs to IFN-b or IFN-a prior to the induction of proliferation by
phytohaemagglutinin (PHA) (Figure 1A). PHA-induced
proliferation of CD4+ T cells was higher in newborns
compared to adults (Figure 1B). In the absence of PHA, a
small percentage of CD4+ T cells proliferated spontaneously,
which was significantly higher in newborns (1.9% ± 0.3)
compared to adults (1.1% ± 0.3) (Figure 1B). Exposure to
IFN-b inhibited PHA-induced proliferation of adult CD4+ T
cells in a dose-dependent fashion and the inhibitory effect of
IFN-b was lower on newborn CD4+ T cells compared to adult
CD4+ T cells (Figure 1C). Due to the high variance in PHA-
induced proliferation between individuals, we normalized the
data and observed similar results: the inhibitory effect of IFN-b
was lower on newborn CD4+ T cells compared to adult CD4+ T
cells (Figure 1D). Contrary, exposure to IFN-a had no effect on
newborn and adult CD4+ T cell proliferation (Figure 1E).
Comparable results were obtained for newborn and adult
CD8+ T cells (Supplementary Figures 1A–D) indicating a low
IFN-b-mediated inhibition of CD4+ and CD8+ T cell
proliferation in newborns.
Low RSV-Induced Inhibition of T Cells
Is IFNAR-Dependent in Adults and in
Newborns
Our group previously showed that exposure to RSV induces type
I IFNs by newborn and adult MCs (10). To confirm the
inhibitory role of type I IFNs during a clinically relevant viral
infection in early life, the effect of RSV on T cell proliferation was
investigated. Exposure to RSV induced a dose-dependent
inhibition of CD4+ T cell proliferation in newborns and adults
(Figure 1F). In line with our observation regarding IFN-b, the
inhibition of CD4+ T cell proliferation after exposure to RSV was
lower in newborns compared to adults (Figure 1F). Comparable
results were obtained for newborn and adult CD8+ T cells
(Supplementary Figure 1E). We, next, determined whether
exposure to RSV inhibits T cell proliferation via soluble
mediators and IFNAR signaling. MCs were exposed to RSV for
24h and the supernatant was stored. Subsequently, MCs from
different donors were incubated with supernatant derived from
RSV exposed MCs (RSV-MC) to investigate the effect of soluble
mediators on T cell proliferation. Exposure to RSV-MC
supernatant inhibits CD4+ T cell proliferation and the
inhibitory effect was lower in newborn CD4+ T cells compared
to adults (Figures 1G, H). In newborns, blocking of IFNAR2 did
not affect the inhibitory effect of RSV on CD4+ T cell
proliferation (Figure 1I). In adults, IFNAR2 signaling
contributed to the inhibitory effect of RSV on CD4+ T cell
proliferation (Figure 1J). Comparable results were obtained for
CD8+ T cells (Supplementary Figures 1F, G). These data
indicate that RSV-induced IFNAR2-dependent inhibition of T
cells is only present in adults and not in newborns.
Low IFN-b-Mediated Inhibition of
Retinoblastoma Protein Phosphorylation
and Proliferation in Isolated Newborn
CD4+ T Cells
To investigate the direct effect of IFN-b on CD4+ T cells, CD4+ T
cells were isolated fromMCs. Isolated CD4+ T cells were exposed to
IFN-b and, subsequently, CD3/CD28 beads were used to stimulate
the T cell receptor (TCR) and induce CD4+ T cell proliferation.
TCR-induced proliferation of CD4+ T cells was similar between
newborns and adults (Figure 2A). Exposure to IFN-b inhibits CD4+
T cell proliferation and the IFN-b-mediated inhibition was lower in
newborns compared to adults (Figure 2B). These results are in line
with our previous results regarding IFN-b-mediated inhibition of
CD4+ T cell proliferation in a model of MCs. No increase of cell
death was observed after exposure of CD4+ T cells to IFN-b
(Supplementary Figure 2A). To further dissect the IFN-b-
mediated CD4+ T cell inhibition, phosphorylation of
retinoblastoma protein (Rb), an important requisite for T cell
proliferation (11), was measured (Figure 2C). TCR-induced
phosphorylation of Rb was similar between newborn and adult
Jans et al. IFN-b-Mediated Regulation of Newborn T Cells
Frontiers in Immunology | www.frontiersin.org April 2021 | Volume 12 | Article 6529653
CD4+ T cells (Figure 2D). Exposure to IFN-b inhibits TCR-induced
phosphorylation of Rb in CD4+ T cells and this inhibition by IFN-b
was lower in newborn CD4+ T cells compared to adults (Figure 2E),
which corresponds with the observed differences in CD4+ T cell
proliferation between newborns and adults.
IFN-b-Mediated Inhibition of Cytokine
Release Is Absent in Newborn CD4+
T Cells
To evaluate the effect of IFN-b on other effector functions than
CD4+ T cell proliferation and phosphorylation of Rb, CD4+ T cells
were exposed to IFN-b and the capacity to produce pro- and anti-
inflammatory cytokines, respectively tumor necrosis factor (TNF)
and interleukin 10 (IL-10), was determined. TCR-induced
production of TNF and IL-10 by newborn CD4+ T cells was low
compared to adults (Supplementary Figures 2B, C). Exposure to
IFN-b inhibits the TCR-induced production of TNF and IL-10 by
adult CD4+ T cells, whereas no inhibitory effect of IFN-b on
cytokine production by newborn CD4+ T cells was observed
(Figures 2F, G). IL-10 production by regulatory CD4+ T cells
(Tregs) has been implicated in the inhibition of conventional CD4+
T cells (12). The inhibitory effect of IFN-b on IL-10 production by
adult T cells suggests that IFN-b-mediated inhibition of T cells most
likely does not depend on the production of IL-10 by Tregs. To
confirm these results, we depleted Tregs from CD4+ T cells
(Supplementary Figure 2D) and showed that depletion of Tregs
did not affect IFN-b-mediated inhibition of adult CD4+ T cell
proliferation (Supplementary Figures 2D, E). These experiments
show that the inhibitory effect of IFN-b on cytokine production by
CD4+ T cells, a different effector function than proliferation, is also
low in newborns compared to adults.
IFN-b Induces Comparable Levels of
Phosphorylated STAT1 and Transcription
Factors in Newborn and Adult CD4+ T Cells
The observation of a low inhibitory effect on isolated newborn
CD4+ T cells by IFN-b led to the hypothesis that IFN-b may
differentially induce downstream signaling in newborn CD4+ T
A
C D E F
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FIGURE 1 | IFN-b-mediated inhibition of CD4 +T cell proliferation is reduced in newborns. (A) Representative gating strategy: CD3+ cells were identified from MCs
followed by CD4+ and CD8+ cells to identify respectively CD4+ T cells and CD8+ T cells. CFSE fluorescence was used to determine the percentage of proliferating
T cells. (B) Percentage of proliferating CD4+ T cells after incubation of CBMC (newborn) or PBMC (adults) with PHA for 72h. (N=14-19). (C–F) CMBCs or PBMCs
were pre-incubated with medium, IFN-b (C-D), IFN-a (E), or RSV (F) for 24h and, subsequently, incubated with PHA for 72h to induce proliferation. Proliferation of
CD4+ T cells after pre-incubation with medium was normalized for (D–F). For this, the proliferation of T cells in the condition with only medium was set to 100%.
(N=5-6). (G, H) CBMCs (G) or PBMCs (H) were pre-incubated with supernatant derived from MCs exposed to medium or supernatant derived from MCs exposed
to RSV and, subsequently, incubated with PHA for 72h to induce proliferation. Proliferation of CD4+ T cells after pre-incubation with supernatant derived from MCs
exposed to medium was set to 100%. (N=5-7). (I, J) CBMCs (I) or PBMCs (J) were incubated with medium, blocking antibodies against IFNAR2 or isotype controls
for 1h followed by exposure to medium or RSV for 24h and PHA for 72h to induce proliferation. Proliferation of CD4+ T cells after pre-incubation with medium was
set to 100%. (N=5-6). Data are presented as means ± SEM. NS = not significant. * = P<0.05. ** = P<0.01. *** = P<0.001. ns, not significant.
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cells compared to adults. IFN-b binds IFNAR1 and IFNAR2,
induces phosphorylation of signal transducer and activator
of transcription 1 (STAT1) followed by transcription of
multiple interferon-stimulated genes (ISG) (13). Therefore, we
analyzed the expression of IFNAR on newborn and adult T cells
and downstream signaling including phosphorylation of STAT1
and transcription of multiple ISG such as STAT1, STAT2 and
interferon regulatory factor 9 (IRF9) mRNA (13). Using
CD45RA and CD27 expression, we categorized CD4+ T cells
into naïve (CD45RA+CD27+), central memory (CD45RA-
CD27+), effector memory (CD45RA-CD27-) and terminally
differentiated (CD45RA+CD27-) CD4+ T cells (Figure 3A) (9).
The expression level of IFNAR1 and IFNAR2 was higher on
newborn naïve CD4+ T cells and newborn central memory CD4+
T cells compared to adults (Figures 3B, C). IFNAR1/2
expression could not be determined on newborn effector
memory and terminally differentiated T cells as these
populations are barely present or undetectable in newborns
(<0.01%) (Supplementary Figures 3A, B). In adults, IFNAR1
and IFNAR2 expression was higher on naïve T cells compared to
effector memory and terminally differentiated T cells
(Supplementary Figures 3C, D). STAT1 phosphorylation in
CD4+ T cells was detected after 5 minutes exposure of isolated
CD4+ T cells to IFN-b and comparable between newborn and
adult CD4+ T cells (Figure 3D). STAT1 phosphorylation leads to
nuclear accumulation and transcription of transcription factors
STAT1, STAT2 and IRF9. Binding of these transcription factors
to IFN-stimulated response element (ISRE) induces IFN type-I
inducible genes (ISGs). Baseline expression and the induction of





FIGURE 2 | IFN-b-mediated inhibition of bead-induced CD4+ T cell proliferation, phosphorylation of Rb and cytokine production is reduced in newborns.
(A) Percentage of proliferating CD4+ T cells after incubation of isolated adult and newborn CD4+ T cells with CD3/CD28 beads for 72h. (N=6-8). (B) Newborn and
adult CD4+ T cells were pre-incubated with medium, or IFN-b for 24h and, subsequently, incubated with CD3/CD28 beads for 72h to induce proliferation.
Proliferation after pre-incubation with medium was set to 100%. (N=6-8). (C) Representative gating strategy: CD4+ T cells were isolated from PBMC or CBMC and
phosphorylation of Rb was determined. (D) Percentage of CD4+ T cells positive for Rb phosphorylation after incubation of isolated adult and newborn CD4+ T cells
with CD3/CD28 beads for 72h. (E) Newborn and adult CD4+ T cells were pre-incubated with medium, or IFN-b for 24h and, subsequently, incubated with CD3/
CD28 beads for 72h to induce phosphorylation of Rb. Phosphorylation of Rb after pre-incubation with medium was set to 100%. (F, G): Newborn and adult CD4+
T cells were pre-incubated with medium, or IFN-b for 24h and, subsequently, incubated with CD3/CD28 beads for 72h to induce cytokine production of TNF (F) and
IL-10 (G). Data are presented as means ± SEM. * = P<0.05. ** = P<0.01. *** = P<0.001.
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newborn and adult CD4+ T cells (Figures 3E–G). These
similarities between newborn and adult CD4+ T cells indicate
that the expression of IFNAR and downstream signaling, such as
the phosphorylation of STAT1 and the induction of
transcription factors STAT1, STAT2 and IRF9 are not
responsible for the observed low IFN-b-mediated T-cell
inhibition in newborn CD4+ T cells.
Contrary to Adults, Newborn Naïve CD4+
T Cells Lack the Induction of p21 After
Exposure to IFN-b
To elucidate our phenotype in which IFN-b exerts a low anti-
proliferative effect on neonatal CD4+ T cells, the two most
important IFN-induced cell cycle inhibitors that act as a major
effector molecule of cell cycle arrest; cyclic-dependent kinase
inhibitor (CDKI) p27 and p21 (14, 15) were investigated. IFN-b
did not induce p27 mRNA in newborn and adult CD4+ T cells
(Figure 4A). Newborn CD4+ T cells also lack the induction of
p21, whereas p21 was induced in adult CD4+ T cells after
exposure to IFN-b (Figure 4B). The expression of p21 is
tightly regulated via p53-dependent and p53-independent
pathways (14–16). IFN-b did not induce p53 mRNA in
newborn and adult CD4+ T cells (Figure 4C), indicating that
in our assay the transcription of p53 is not affected by exposure
of newborn or adult CD4+ T cells to IFN-b. A major difference
between neonatal and adult CD4+ T cells is the high number of
memory CD4+ T cells in adults. Therefore, the memory fraction
was removed from CD4+ T cells and the expression of p21 was
measured after exposure of isolated naïve CD4+ T cells from
newborns and adults (Figure 4D) to IFN-b. In accordance with
our data derived from total CD4+ T cells, IFN-b did not induce
p21 in naïve newborn CD4+ T cells, whereas IFN-b-mediated
induction of p21 was still present in adult naïve CD4+ T cells






FIGURE 3 | High IFNAR expression and similar induction of phosphorylated STAT1 and STAT1-induced transcription factors in newborn CD4+ T cells. (A) Representative
gating to determine IFNAR1 and IFNAR2 expression on CD4+ T cell subsets. CD3, CD4 and CD8 was used to identify CD4+ T cells and CD8+ T cells. CD45RA and CD27
was used to identify T cell subsets: naïve (CD45RA+CD27+), central memory (CD45RA-CD27+), effector memory (CD45RA-CD27-) and terminally differentiated
(CD45RA+CD27-) T cells. (B) Expression of IFNAR1 and IFNAR 2 on newborn and adults naïve (B) and central memory (C) T cells. (N=4-5). (D) Presence of phosphorylated
STAT1 in newborn and adult CD4+ T cells upon exposure to IFN-b. (N=3-6). (E–G) Expression of (E) STAT1, (F) STAT2 and (G) IRF9 mRNA in newborn and adult CD4+
T cell after exposure to medium or IFN-b for 2h. (N=5-6). Data are presented as means ± SEM. * = P<0.05. ** = P<0.01. *** = P<0.001.
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not responsible for the induction of p21 in adult CD4+ T cells
and show an intrinsic difference between naïve CD4+ T cells
from newborns and adults in which newborns lack the induction
of cell cycle inhibitor p21 after exposure to IFN-b.
DISCUSSION
The goal of this study was to determine the differential effects of
IFN-b on newborn CD4+ T cell functionality compared to adults.
It was demonstrated for the first time that IFN-b has a low
inhibitory effect on human newborn CD4+ T cells with regards to
(a) proliferation, (b) phosphorylation of Rb and (c) cytokine
production upon TCR stimulation compared to adult CD4+ T
cells. Newborn CD4+ T cells have a distinct pathway of IFN-b-
signaling in which (d) newborn CD4+ T cells express higher
levels of IFNAR1 and IFNAR2 compared to adults, (e) IFN-b-
mediated STAT1 phosphorylation and induction of
transcription factors STAT1, STAT2 and IRF9 are comparable
between newborn and adult CD4+ T cells but (f) newborn total
and naïve CD4+ T cells, contrary to adults, lack the induction of
the cell cycle inhibitor p21 after exposure to IFN-b (Figure 5).
In this study, we have shown that IFN-b, contrary to IFN-a,
inhibits the capacity of newborn and adult T cells to proliferate.
Previous reports describe similar differences between IFN-a and
IFN-b that may depend on longer receptor binding by IFN-b
(17), higher affinity binding by IFN-b (18), differential gene
induction by IFN-a and IFN-b (18) or due to the ability of
INF-b, and not IFN-a, to induce dimerization of IFNAR1 and
IFNAR2 (19). In both our model of MCs and isolated CD4+ T
cells, IFN-b has a low inhibitory effect on T cell proliferation in
newborn CD4+ T cells. Therefore, we confirmed our original
observation that IFN-b has a low inhibitory effect on newborn T
cells compared to adults by looking at multiple effector functions
of CD4+ T cells , such as cytokine production and
phosphorylation of Rb.
The following sequence of IFN-b-mediated signaling was
investigated in newborns and adults: Expression of the
receptor INFAR1/2, phosphorylation of STAT1 and induction
of an important transcriptional complex called ISG factor 3
(ISFG3) that includes the transcription factors STAT1, STAT2
and IRF9 (20). We have shown that these IFN-b-mediated
processes are comparable between newborn and adult CD4+ T
cells. Although the neonatal immune system is considered
immature, our data indicate that a substantial part of IFN-b-
mediated signaling is comparable between newborns and adults.
A large number of transcriptional factors are transcribed after
IFN-b-mediated activation of ISFG3. To elucidate the observed
A B
C D E
FIGURE 4 | Contrary to adults, newborn naïve CD4+ T cells lack the induction of p21 after exposure to IFN-b. (A–C) Expression of p27, p21 and p35 after
exposure of newborn and adult CD4+ T cells to IFN-b for 24h. (N=4-8). (D) Subset analysis after isolation of total and naïve CD4+ T cells in newborns and adults.
(E) Expression of p21 after exposure of newborn and adult naïve CD4+ T cells. (N=4). Data are presented as means ± SEM. * = P<0.05. ** = P<0.01.
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phenotype in which IFN-b exerts an anti-proliferative effect, we
specifically examined p21, because it acts as the major effector
molecule of cell cycle arrest (14). Previous literature has already
shown the causal relationship between the induction of p21 and
its anti-proliferative effect on cells (14, 21–23). The requirement
of p21 for the anti-proliferative effect of type I IFNs has been
observed in cardiomyocytes (21), smooth muscle cells (22),
keratinocytes (24) and epithelial cells (25). Although this study
did not study the requirement of p21 in the anti-proliferative
effect of IFN-b on T cells, we hypothesize that, based on previous
literature, the lack of induction of p21 in newborns may explain
the low inhibitory effect of IFN-b on newborn CD4+ T cells. We
first hypothesized that the induction of p21 in adults was a result
of the presence of a high number of memory CD4+ T cells in
adults. However, isolation of naïve CD4+ T cells led to similar
results in which, again, only newborns lack the induction of p21
after exposure to IFN-b. Many factors contribute to the
induction of p21 and can be divided into p53-dependent and
p53-independent mechanisms (26). In our model, p53 was not
induced on a transcriptional level in adults after exposure to
IFN-b, which was comparable with newborn CD4+ T cells.
However, regulation of p53 also occurs post-transcriptional
(27). Therefore, IFN-b may have a differential effect on the
post-transcriptional regulation of p53 in newborn CD4+ T cells
compared to adults. Besides the lack of induction of p21 in
newborn CD4+ T cells, we also observed a low baseline
expression of p21 in naïve newborn CD4+ T cells compared to
adults which is consistent with the absence of p21 in fetal tissues
observed in previous literature (28). From a developmental
perspective, low expression of p21 could be essential during a
period of growth such as during the fetal and neonatal period.
On the other hand, the absent induction of p21 in newborn
FIGURE 5 | Low CD4+ T cell suppression and lack of cell cycle inhibitor p21 in newborns upon exposure to IFN-b. A graphical abstract is depicted that summarizes
the main results of this study: Newborn CD4+ T cells have a distinct pathway of IFN-b-signaling in which (1) newborn CD4+ T cells express higher levels of IFNAR1
and IFNAR2 compared to adults, (2) IFN-b-mediated STAT1 phosphorylation and induction of transcription factors STAT1, STAT2 and IRF9 are comparable between
newborn and adult CD4+ T cells but (3) newborn total and naïve CD4+ T cells, contrary to adults, lack the induction of the cell cycle inhibitor p21 after exposure to
IFN-b. In addition, IFN-b has a low inhibitory effect on newborn CD4+ T cells with regards to (1) proliferation, (2) phosphorylation of Rb and (3) cytokine production
upon TCR stimulation compared to adult CD4+ T cells (red lines).
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CD4+ T cel ls could contribute to T cel l-mediated
immunopathology during infections, because p21 limits
overactivation of T cells (29). Differences in expression levels,
including the expression of p21, between newborn and adult
CD4+ T cells could be a result of epigenetic changes, because
aging is associated with epigenetic changes. Zhao et al.
investigated the epigenome of CD4+ T cells from newborns
and adults (30). This study did not observe a difference in
methylation of p21 between newborn and adult CD4+ T cells.
Therefore, it is unlikely that epigenetic changes in p21 are
responsible for the lack of induction of p21 in newborn CD4+
T cells. Interestingly, epigenetic changes between newborn and
adult CD4+ T cells were observed in the methylation of
transcription factors that are involved in the p53-independent
regulation of p21. SMAD3, STAT3, STAT5, NEUROD1 are
transcription factors that induce p21 in a p53-independent
manner and, in addition, are hypermethylated in newborn
CD4+ T cells compared to adult CD4+ T cells (30). Because
hypermethylation reduces gene expression, we propose that the
lack of induction of p21 in newborn CD4+ T cells could be a
result of hypermethylation of regions containing SMAD3,
STAT3, STAT5 and/or NEUROD1 in newborn CD4+ T cells.
It is not yet possible to predict whether the low inhibitory
effect of IFN-b on newborn CD4+ T cells would be protective or
detrimental for disease progression during infection in vivo.
Proliferation and expansion of CD4+ T cells are pivotal for
growth and the development of an adaptive immune response
after birth and the observed low inhibitory effect of IFN-b could
be beneficial for newborns to allow proper growth. On the other
hand, neonatal infections can be characterized by exuberant
inflammation and newborn CD4+ T cells can secrete higher
levels of cytokines such as IL-4 compared to adults (31). Low
inhibition of newborn CD4+ T cells by IFN-b could be
responsible for the high production of T-cell-derived cytokines
and, thereby, result in a defective control of CD4+ T-cell-
dependent inflammation leading to inflammation-mediated
disease progression in vivo.
In conclusion, IFN-b-mediated pathways leading to the
induction of STAT1 phosphorylation and the induction of
several transcription factors were comparable between
newborn and adult CD4+ T cells. Signals starting from the
induction of p21 such as expression of p21, suppression of Rb
phosphorylation and inhibition of the capacity of CD4+ T cells to
proliferate and produce cytokines were lower in newborns
compared to adults. Therefore, the lack of cell cycle inhibitor
p21 was pinpointed as an important difference between newborn
and adult CD4+ T cells during IFN-b-mediated T cell
suppression. This study provides novel insights into the
regulation of T-cell-mediated immune responses that play an
important role during early life infections.
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Supplementary Figure 1 | IFN-b-mediated inhibition of CD8 +T cell proliferation
is reduced in newborns. (A) Percentage of proliferating CD8+ T cells after incubation
of PBMC (adult) or CBMC (newborns) with PHA for 72h. (N=14-19).
(B–E) CMBCs or PBMCs were pre-incubated with medium, IFN-b (B, C), IFN-a
(D) or RSV (E) for 24h and, subsequently, incubated with PHA for 72h to induce
proliferation. Proliferation of CD4+ T cells after pre-incubation with medium was
normalized for Supplemental Figures 1C–E. For this, the proliferation of T cells in
the condition with only medium was set to 100%. (N=5-6). (N=5-6). (F, G) CBMC
(F) or PBMC (G) were incubated with medium, blocking antibodies against IFNAR2
or isotype controls for 1h followed by exposure to medium or RSV for 24h and PHA
for 72h to induce proliferation. Proliferation of CD8+ T cells after pre-incubation with
medium was set to 100%. (N=5-6). NS = not significant. * = P<0.05. ** = P<0.01.
*** = P<0.001.
Supplementary Figure 2 | Low bead-induced cytokine production by newborn
CD4+ T cells and no effect of depletion of Tregs on the inhibitory effect of IFN-b in
adults. (A) Cell death of newborn and adult CD4+ T cells after incubation with
medium or IFN-b for 24h followed by incubation with CD3/CD28 beads for 72h.
(N=4-6). (B, C). Production of TNF (B) and IL-10 (C) by newborn and adult CD4+
T cells after exposure to CD3/CD28 beads for 72h. (N=5-7). (D) Representative
samples of CD4+ T cells with and without CD25+ regulatory T cells (Tregs). (E) Adult
CD4+ T cells and adult CD4+ T cells depleted of CD25+ cells were pre-incubated
with IFN-b for 24h followed by incubation with CD3/CD28 beads to induce
proliferation. Proliferation of CD4+ T cells after pre-incubation with medium was set
to 100%. Data are presented as means ± SEM. * = P<0.05. ** = P<0.01. *** =
P<0.001.
Supplementary Figure 3 | (A) Representative gating to determine IFNAR1 and
IFNAR2 expression on CD4+ T cell subsets. CD3, CD4 and CD8 was used to
identify CD4+ T cells and CD8+ T cells. CD45RA and CD27 was used to identify
T cell subsets: naïve (CD45RA+CD27+), central memory (CD45RA-CD27+), effector
memory (CD45RA-CD27-) and terminally differentiated (CD45RA+CD27-) T cells.
(B) Percentage of T cell subsets in newborn and adults. (N=4). (C, D) Expression of
INFAR1 and IFNAR 2 on adult CD4+ T cell subsets (C) and adult CD8+ T cell
subsets. (N=5). Data are presented as means ± SEM. * = P<0.05. ** = P<0.01.
*** = P<0.001.
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